Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Familial platelet disorder with predisposition to acute myelogenous leukaemia (FPD/AML, MIM 601399) is an autosomal dominant disorder characterized by qualitative and quantitative platelet defects, and propensity to develop acute myelogenous leukaemia (AML). Informative recombination events in 6 FPD/AML pedigrees with evidence of linkage to markers on chromosome 21q identified an 880-kb interval containing the disease gene. Mutational analysis of regional candidate genes showed nonsense mutations or intragenic deletion of one allele of the haematopoietic transcription factor CBFA2 (formerly AML1) that co-segregated with the disease in four FPD/AML pedigrees. We identified heterozygous CBFA2 missense mutations that co-segregated with the disease in the remaining two FPD/AML pedigrees at phylogenetically conserved amino acids R166 and R201, respectively. Analysis of bone marrow or peripheral blood cells from affected FPD/AML individuals showed a decrement in megakaryocyte colony formation, demonstrating that CBFA2 dosage affects megakaryopoiesis. Our findings support a model for FPD/AML in which haploinsufficiency of CBFA2 causes an autosomal dominant congenital platelet defect and predisposes to the acquisition of additional mutations that cause leukaemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The transcription factor RUNX-1 plays a key role in megakaryocyte differentiation and is mutated in cases of myelodysplastic syndrome and leukemia.”
From Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. (2009) · cites this paper as [48]
In the citing paper
“Germ line mutations in RUNX-1 cause familial platelet disorder with the propensity to develop acute myelogenous leukemia (FPD/AML), a rare autosomal dominant disorder characterized by quantitative and qualitative platelet defects and a high incidence of developing myelodysplastic syndrome (MDS) and leukemia”
From Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. (2009) · cites this paper as [48]
Citations
Cites
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
de Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355 · cited 1×
“Fusion of PDGF Receptor β to a novel ETS-like gene, TEL, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation.”
BackgroundWang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A. H., & Speck, N. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3444 · Cited by 1,178
Self-citationGolub, T. R., Barker, G. F., Lovett, M., & Gilliland, D. G. (1994) · Cell · doi:10.1016/0092-8674(94)90322-0 · Cited by 1,155
Self-citationOncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis.
Weinberg, R. A. (1989) · PubMed · Cited by 949
The murine gene p27Kip1 is haplo-insufficient for tumour suppression
Fero, M. L., Randel, E., Gurley, K. E., Roberts, J. M., & Kemp, C. J. (1998) · Nature · doi:10.1038/24179 · Cited by 784
Fusion Between Transcription Factor CBFβ/PEBP2β and a Myosin Heavy Chain in Acute Myeloid Leukemia
Liu, P., Tarlé, S. A., Hajra, A., Claxton, D. F., Marlton, P., Freedman, M., Siciliano, M. J., & Collins, F. S. (1993) · Science · doi:10.1126/science.8351518 · Cited by 732 · cited 1×
“; the CBFB / MYH11 fusion associated with inv(16) myelomonocytic leukaemia with eosinophili”
BackgroundFusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
Golub, T. R., Barker, G. F., Bohlander, S. K., Hiebert, S. W., Ward, D. C., Bray-Ward, P., Morgan, E., Raimondi, S. C., Rowley, J. D., & Gilliland, D. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4917 · Cited by 704
Self-citationShivdasani, R. A., Rosenblatt, M. F., Zucker-Franklin, D., Jackson, C. W., Hunt, P., Saris, C. J. M., & Orkin, S. H. (1995) · Cell · doi:10.1016/0092-8674(95)90531-6 · Cited by 693 · cited 1×
“It is notable that mice hemizygous for genes required for megakaryopoiesis, such as Gata1 , Nfe2 and fog , have apparent platelet defect”
BackgroundShivdasani, R. A., Fujiwara, Y., McDevitt, M. A., & Orkin, S. H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3965 · Cited by 674 · cited 1×
“It is notable that mice hemizygous for genes required for megakaryopoiesis, such as Gata1 , Nfe2 and fog , have apparent platelet defect”
BackgroundErickson, P., Gao, J., Chang, K., Look, T., Whisenant, E., Raimondi, S., Lasher, R., Trujillo, J., Rowley, J., & Drabkin, H. (1992) · Blood · doi:10.1182/blood.v80.7.1825.1825 · Cited by 631 · cited 1×
“; fusion of CBFA2 and CBFA2T1 (formerly ETO ) in t(8;21) AML, M2 subtyp”
The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion
Romana, S., Mauchauffe, M., Le Coniat, M., Chumakov, I., Le Paslier, D., Berger, R., & Bernard, O. (1995) · Blood · doi:10.1182/blood.v85.12.3662.bloodjournal85123662 · Cited by 530
Thirman, M. J., Gill, H. J., Burnett, R. C., Mbangkollo, D., McCabe, N. R., Kobayashi, H., Ziemin-van der Poel, S., Kaneko, Y., Morgan, R., Sandberg, A. A., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309233291302 · Cited by 502 · cited 1×
“A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias.”
BackgroundMiyoshi, H., Kozu, T., Shimizu, K., Enomoto, K., Maseki, N., Kaneko, Y., Kamada, N., & Ohki, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05933.x · Cited by 498
High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia
Romana, S., Poirel, H., Leconiat, M., Flexor, M., Mauchauffe, M., Jonveaux, P., Macintyre, E., Berger, R., & Bernard, O. (1995) · Blood · doi:10.1182/blood.v86.11.4263.bloodjournal86114263 · Cited by 427
THE CRITICAL ROLE OF CHROMOSOME TRANSLOCATIONS IN HUMAN LEUKEMIAS
Rowley, J. D. (1998) · Annual Review of Genetics · doi:10.1146/annurev.genet.32.1.495 · Cited by 397 · cited 1×
“A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias.”
BackgroundOsato, M., Asou, N., Abdalla, E., Hoshino, K., Yamasaki, H., Okubo, T., Suzushima, H., Takatsuki, K., Kanno, T., Shigesada, K., et al. (1999) · Blood · doi:10.1182/blood.v93.6.1817.406k36_1817_1824 · Cited by 397
Okuda, T., Cai, Z., Yang, S., Lenny, N., Lyu, C.-J., van Deursen, J. M. A., Harada, H., & Downing, J. R. (1998) · Blood · doi:10.1182/blood.v91.9.3134 · Cited by 372
The t(8;21) Fusion Protein Interferes with AML-1B-Dependent Transcriptional Activation
Meyers, S., Lenny, N., & Hiebert, S. W. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.4.1974 · Cited by 368 · cited 1×
“Previous mutation analyses of the Runt domain demonstrated that elimination of as few as 10 amino acids from its C terminus disrupts DNA-binding activit”
BackgroundYergeau, D. A., Hetherington, C. J., Wang, Q., Zhang, P., Sharpe, A. H., Binder, M., Marín-Padilla, M., Tenen, D. G., Speck, N. A., & Zhang, D.-E. (1997) · Nature Genetics · doi:10.1038/ng0397-303 · Cited by 346 · cited 1×
“30 ) that lack sequences C terminal to the Runt domain required for trans -activation, as well as for the protein products of chromosomal translocations involving CBFA2 in human leukaemia”
BackgroundSelf-citationFearon, E. R., Burke, P. J., Schiffer, C. A., Zehnbauer, B. A., & Vogelstein, B. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607033150103 · Cited by 285 · cited 5×
“The t(12;21) converts AML-1B from an activator to a repressor of transcription.”
BackgroundInfluentialCastilla, L. H., Wijmenga, C., Wang, Q., Stacy, T., Speck, N. A., Eckhaus, M., Marín-Padilla, M., Collins, F. S., Wynshaw-Boris, A., & Liu, P. P. (1996) · Cell · doi:10.1016/s0092-8674(00)81388-4 · Cited by 284
Self-citationNakamura, T., Alder, H., Gu, Y., Prasad, R., Canaani, O., Kamada, N., Gale, R. P., Lange, B., Crist, W. M., & Nowell, P. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4631 · Cited by 278 · cited 1×
“; and MLL fusions to a spectrum of partner genes in leukaemias with 11q23 translocation”
BackgroundThe t(12;21) Translocation Converts AML-1B from an Activator to a Repressor of Transcription
Hiebert, S. W., Sun, W., Nathan Davis, J., Golub, T., Shurtleff, S., Buijs, A., Downing, J. R., Grosveld, G., Roussel, M. F., Gary Gilliland, D., et al. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1349 · Cited by 272
Self-citationTanaka, T., Tanaka, K., Ogawa, S., Kurokawa, M., Mitani, K., Nishida, J., Shibata, Y., Yazaki, Y., & Hirai, H. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07008.x · Cited by 224
Tevosian, S. G., Deconinck, A. E., Cantor, A. B., Rieff, H. I., Fujiwara, Y., Corfas, G., & Orkin, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.3.950 · Cited by 210
Tissue specificity of X-chromosome inactivation patterns
Gale, R., Wheadon, H., Boulos, P., & Linch, D. (1994) · Blood · doi:10.1182/blood.v83.10.2899.2899 · Cited by 179
Kowalska, M. A., Ratajczak, J., Hoxie, J., Brass, L. F., Gewirtz, A., Poncz, M., & Ratajczak, M. Z. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01169.x · Cited by 143
Self-citationIncidence of TEL/AML1 Fusion in Children With Relapsed Acute Lymphoblastic Leukemia
Loh, M. L., Silverman, L. B., Young, M. L., Neuberg, D., Golub, T. R., Sallan, S. E., & Gilliland, D. G. (1998) · Blood · doi:10.1182/blood.v92.12.4792 · Cited by 115
Self-citationCore-binding factor: a central player in hematopoiesis and leukemia.
Speck, N. A., Stacy, T., Wang, Q., North, T. E., Gu, T.-L., Miller, J., Binder, M., & Marin-Padilla, M. (1999) · PubMed · Cited by 114
Self-citationA serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias
Morrissey, J. J., Tkachuk, D., Milatovich, A., Francke, U., Link, M., & Cleary, M. L. (1993) · Blood · doi:10.1182/blood.v81.5.1124.1124 · Cited by 112 · cited 1×
“; and MLL fusions to a spectrum of partner genes in leukaemias with 11q23 translocation”
BackgroundHo, C., Otterud, B., Legare, R., Varvil, T., Saxena, R., DeHart, D., Kohler, S., Aster, J., Dowton, S., Li, F., et al. (1996) · Blood · doi:10.1182/blood.v87.12.5218.bloodjournal87125218 · Cited by 110 · cited 2×
“Examples include the PML/RARA fusion in t(15;17) associated with acute promyelocytic leukaemia5; fusion of CBFA2 and CBFA2T1 (formerly ETO) in t(8;21) AML, M2 subtype6,7; the CBFB/MYH11 fusion associated with inv(16) myelomonocytic leukaemia with eosinophilia8; and MLL fusions to a spectrum of partner genes in leukaem…”
BackgroundSelf-citationStudies of a familial platelet disorder
Dowton, S., Beardsley, D., Jamison, D., Blattner, S., & Li, F. (1985) · Blood · doi:10.1182/blood.v65.3.557.557 · Cited by 108
Self-citationLEVANON, D., BERNSTEIN, Y., NEGREANU, V., GHOZI, M. C., BAR-AM, I., ALOYA, R., GOLDENBERG, D., LOTEM, J., & GRONER, Y. (1996) · DNA and Cell Biology · doi:10.1089/dna.1996.15.175 · Cited by 94 · cited 1×
“Such a function has been proposed for naturally occurring splice variants of CBFA2 (ref”
BackgroundBerardi, M. J., Sun, C. C., Zehr, M., Abildgaard, F., Peng, J. W., Speck, N. A., & Bushweller, J. H. (1999) · Structure · doi:10.1016/s0969-2126(00)80058-1 · Cited by 93
Self-citationKagoshima, H., Akamatsu, Y., Ito, Y., & Shigesada, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.33074 · Cited by 92 · cited 1×
“In the case of R201, a ten amino acid deletion of this region of the Runt domain has been shown to abolish DNA bindin”
BackgroundRubnitz, J. E., Behm, F. G., Wichlan, D., Ryan, C., Sandlund, J. T., Ribeiro, R., Rivera, G. K., Hancock, M., Relling, M. V., Evans, W., et al. (1999) · Leukemia · doi:10.1038/sj.leu.2401257 · Cited by 80
Clonal evolution in acute myeloid leukemia [editorial; comment]
Busque, L., & Gilliland, D. G. (1993) · Blood · doi:10.1182/blood.v82.2.337.337 · Cited by 74
Self-citationBiochemical and Biophysical Properties of the Core-binding Factor α2 (AML1) DNA-binding Domain
Crute, B. E., Lewis, A. F., Wu, Z., Bushweller, J. H., & Speck, N. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.42.26251 · Cited by 62
Self-citationGerrard, J. M., Israels, E. D., Bishop, A. J., Schroeder, M. L., Beattie, L. L., McNicol, A., Israels, S. J., Walz, D. A., Greenberg, A. H., Ray, M., et al. (1991) · British Journal of Haematology · doi:10.1111/j.1365-2141.1991.tb04529.x · Cited by 55 · cited 2×
“Examples include the PML/RARA fusion in t(15;17) associated with acute promyelocytic leukaemia5; fusion of CBFA2 and CBFA2T1 (formerly ETO) in t(8;21) AML, M2 subtype6,7; the CBFB/MYH11 fusion associated with inv(16) myelomonocytic leukaemia with eosinophilia8; and MLL fusions to a spectrum of partner genes in leukaem…”
BackgroundBae, S.-C., Ogawa, E., Maruyama, M., Oka, H., Satake, M., Shigesada, K., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., & Ito, Y. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.5.3242-3252.1994 · Cited by 52
Clonal evolution in acute myeloid leukemia [editorial; comment]
Busque, L., & Gilliland, D. (1993) · Blood · doi:10.1182/blood.v82.2.337.bloodjournal822337 · Cited by 49
Self-citationHorwitz, M. S., Benson, K. F., Li, F.-Q., Wolff, J., Leppert, M., Hobson, L., Mangelsdorf, M., Yu, S., Hewett, D. R., Richards, R. I., et al. (1997) · The American Journal of Human Genetics · doi:10.1086/514894 · Cited by 45 · cited 1×
“Third, as described here, there are families with an inherited predisposition to develop AML, analogous to other forms of heritable malignancie”
BackgroundSelf-citationKarnofsky Memorial Lecture. Hereditary cancer: theme and variations.
Knudson, A. G. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.10.3280 · Cited by 43
Ratajczak, M. Z., Ratajczak, J., Machaliński, B., Mick, R., & Gewirtz, A. M. (1998) · Blood · doi:10.1182/blood.v91.1.353 · Cited by 40
Self-citationArepally, G. M., Rebbeck, T. R., Song, W., Gilliland, G. D., Maris, J. M., & Poncz, M. (1998) · Blood · doi:10.1182/blood.v92.7.2600 · Cited by 38
Self-citationEffect of hepatocyte growth factor on early human haemopoietic cell development
Ratajczak, M. Z., Marlicz, W., Ratajczak, J., Wasik, M. A., Machaliński, B., Carter, A., & Gewirtz, A. M. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.3563170.x · Cited by 35 · cited 1×
“Colony-forming unit (CFU) assays were performed in duplicate as describe”
MethodSelf-citationAkamatsu, Y., Tsukumo, S., Kagoshima, H., Tsurushita, N., & Shigesada, K. (1997) · Gene · doi:10.1016/s0378-1119(96)00644-0 · Cited by 29
Chromosome translocations: Dangerous liaisons
Rowley, J. D. (1998) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(98)90036-1 · Cited by 21
CBFA2, frequently rearranged in leukemia, is not responsible for a familial leukemia syndrome
Legare, R. D., Lü, D., Gallagher, M., Ho, C. Y., Tan, X., Barker, G. F., Shimizu, K., Ohki, M., Lenny, N. T., Hiebert, S. W., et al. (1997) · Leukemia · doi:10.1038/sj.leu.2400852 · Cited by 15 · cited 1×
“Intragenic deletion of CBFA2 in pedigree 1 We had previously analysed CBFA2 in pedigree 1 in detail and found no evidence for mutation or deletio”
BackgroundSelf-citation
Cited by
A molecular signature of metastasis in primary solid tumors
Ramaswamy, S., Ross, K. N., Lander, E. S., & Golub, T. R. (2003) · Nature Genetics · doi:10.1038/ng1060 · Cited by 2,449
Recurring mutations found by sequencing an acute myeloid leukemia genome
Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219
Greenberg, P. L., Attar, E. C., Bennett, J. M., Bloomfield, C. D., Borate, U., Castro, C. M. D., Deeg, H. J., Frankfurt, O., Gaensler, K. M. L., Garcia-Manero, G., et al. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0104 · Cited by 1,639
Causal Relationship between the Loss of RUNX3 Expression and Gastric Cancer
Li, Q.-L., Ito, K., Sakakura, C., Fukamachi, H., Inoue, K.-I., Chi, X.-Z., Lee, K.-Y., Nomura, S., Lee, C.-W., Han, S.-B., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00690-6 · Cited by 1,028
“To overcome this problem, we obtained cell lines from epithelial cells have been described (Osato et al., 1999; Song et al., 1999).”
MethodAcquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome
Wechsler, J., Greene, M., McDevitt, M. A., Anastasi, J., Karp, J. E., Le Beau, M. M., & Crispino, J. D. (2002) · Nature Genetics · doi:10.1038/ng955 · Cited by 760
“2) [5]/47,XY,+21c[14] 173–174 ins 15 bp Tyr62”
Metadata
- Authors
- Song, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., Loh, M., Felix, C., Roy, D.-C., Busque, L., Kurnit, D., Willman, C., Gewirtz, A. M., Speck, N. A., Bushweller, J. H., Li, F. P., Gardiner, K., Poncz, M., Maris, J. M., & Gilliland, D. G.
- Affiliations
- Brigham and Women's Hospital (US)
- Brown University (US)
- University of Pennsylvania (US)
- Leicester Royal Infirmary (GB)
- St Vincent Hospital (US)
- Hôpital Maisonneuve-Rosemont (CA)
- University of Michigan (US)
- University of New Mexico (US)
- Dartmouth College (US)
- University of Virginia (US)
- Harvard University (US)
- Roosevelt Institute (US)
- Corresponding author
- Gilliland, D. Gary
- ORCID
- Venue
- Nature Genetics
- Published
- 1999-10
- Volume
- 23
- Issue
- 2
- Pages
- 166-175
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1739103212
- Cited by
- 1,100
- References
- 49
- Citations by year
- 2026: 9 · 2025: 23 · 2024: 27 · 2023: 32 · 2022: 29 · 2021: 36 · 2020: 46 · 2019: 33 · 2018: 26 · 2017: 61 · 2016: 54 · 2015: 35 · 2014: 30 · 2013: 33 · 2012: 53
- FWCI
- 25.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (7r29ai039536-04)
- National Cancer Institute (R01CA081932, R01-CA78545, R01 CA81932, R01CA078545)
- National Institute of Allergy and Infectious Diseases (R29 AI39536)
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Keywords
- RUNX1, haploinsufficiency, autosomal dominant inheritance, missense mutations, megakaryopoiesis, megakaryocyte colony formation, platelet disorders, chromosome 21q, nonsense mutation, intragenic deletion
- MeSH terms
- Amino Acid Sequence, Base Sequence, Blood Platelets, Chromosome Mapping, Colony-Forming Units Assay, DNA Mutational Analysis, DNA-Binding Proteins, Family Health, Female, Genotype, Hematopoiesis, Heterozygote, Humans, Male, Megakaryocytes, Molecular Sequence Data, Mutation, Pedigree, Proto-Oncogene Proteins, RNA, Sequence Homology, Nucleic Acid, Thrombocytopenia, Transcription Factors, Leukemia, Myeloid, Acute, Sequence Deletion, Sequence Homology, Amino Acid, In Situ Hybridization, Fluorescence, Microsatellite Repeats, Genetic Predisposition to Disease, Reverse Transcriptase Polymerase Chain Reaction, Core Binding Factor Alpha 2 Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.